LifeMine, Cofactor raise $73M in series A

LifeMine Therapeutics Inc. (Cambridge, Mass.) and Cofactor Genomics Inc. (San Francisco, Calif.) each announced series A financings on Monday, raising a total of $73 million.

LifeMine raised $55 million in a series A round led by WuXi Healthcare Ventures. Foresite Capital, GV, Arch Ventures Partners, Boyu Capital, Blue Pool Capital, Merck & Co. Inc. (NYSE:MRK) and Alexandria Venture Investments also participated...